HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shanthi Marur Selected Research

Shanthi Marur Research Topics

Disease

11Neoplasms (Cancer)
01/2023 - 07/2009
10Squamous Cell Carcinoma of Head and Neck
01/2023 - 04/2008
4Squamous Cell Neoplasms (Squamous Cell Cancer)
03/2016 - 04/2008
3Oropharyngeal Neoplasms
05/2012 - 08/2010
3Fistula
04/2011 - 01/2011
3Wounds and Injuries (Trauma)
04/2011 - 01/2011
2Disease Progression
01/2018 - 07/2009
2Neutropenia
02/2016 - 02/2014
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2015 - 06/2013
2Anaplastic Thyroid Carcinoma
02/2014 - 12/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2017
1Sepsis (Septicemia)
02/2016
1Diarrhea
02/2016
1Pancytopenia
02/2016
1Pneumonia (Pneumonitis)
02/2016
1Abdominal Pain (Pain, Abdominal)
02/2016
1Hypersensitivity (Allergy)
01/2015
1Exanthema (Rash)
01/2015
1Arthralgia (Joint Pain)
01/2015
1Edema (Dropsy)
01/2015
1Hypertension (High Blood Pressure)
02/2014
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
06/2013
1Infections
12/2012
1Neoplasm Metastasis (Metastasis)
11/2012
1Mucositis
05/2012
1Carcinoma (Carcinomatosis)
05/2011
1Laryngeal Neoplasms (Laryngeal Cancer)
01/2011
1Thyroid Neoplasms (Thyroid Cancer)
08/2009
1Prostatic Neoplasms (Prostate Cancer)
07/2009
1Pain (Aches)
07/2009
1Renal Cell Carcinoma (Grawitz Tumor)
10/2008
1Kidney Neoplasms (Kidney Cancer)
10/2008

Drug/Important Bio-Agent (IBA)

3Docetaxel (Taxotere)FDA Link
01/2018 - 10/2008
3Cetuximab (Erbitux)FDA Link
01/2018 - 01/2016
3PlatinumIBA
01/2018 - 06/2013
3ErbB Receptors (EGF Receptor)IBA
01/2016 - 04/2008
2Tadalafil (Cialis)FDA Link
12/2018 - 01/2015
2Biomarkers (Surrogate Marker)IBA
01/2018 - 07/2009
2Paclitaxel (Taxol)FDA LinkGeneric
02/2016 - 02/2014
2Carboplatin (JM8)FDA LinkGeneric
02/2016 - 02/2014
2fosbretabulin (combretastatin A4)IBA
02/2014 - 12/2012
2Capecitabine (Xeloda)FDA Link
07/2009 - 10/2008
1Estrogen Receptor alphaIBA
01/2023
1TNF Receptor-Associated Factor 3IBA
01/2023
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2018
1CytokinesIBA
01/2018
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2018
1cixutumumabIBA
01/2018
1B7-H1 AntigenIBA
01/2018
1Blocking AntibodiesIBA
01/2018
1AfatinibIBA
02/2016
1Explosive Agents (Explosives)IBA
01/2015
1SteroidsIBA
01/2015
1Phosphodiesterase 5 InhibitorsIBA
01/2015
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
01/2015
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2013
1DNA-Directed RNA Polymerases (RNA Polymerase)IBA
06/2013
1Proteins (Proteins, Gene)FDA Link
06/2013
11- (3- C- ethynylribopentofuranosyl)cytosineIBA
06/2013
1TOR Serine-Threonine KinasesIBA
12/2012
1IodineIBA
08/2009
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
07/2009
1ThymidineIBA
07/2009
1Prostate-Specific Antigen (Semenogelase)IBA
07/2009
1Thymidine PhosphorylaseIBA
07/2009

Therapy/Procedure

8Therapeutics
01/2023 - 04/2008
8Drug Therapy (Chemotherapy)
01/2018 - 04/2008
3Radiotherapy
03/2016 - 05/2012
2Induction Chemotherapy
02/2017 - 02/2016
2Neck Dissection (Radical Neck Dissection)
11/2012 - 01/2011
2Mandibular Osteotomy
04/2011 - 04/2011
2Glossectomy
04/2011 - 04/2011
2Laryngectomy
01/2011 - 01/2011
1Aftercare (After-Treatment)
12/2013
1Thyroidectomy
12/2012
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
05/2011
1Pharyngectomy
04/2011
1Length of Stay
01/2011